NGO Vows to Fight Cervical Cancer

0
30


[Vanguard] As part of ways to reduce the rising spate of cervical cancer cases in the country, Sebeccly Cancer Care organization launched the TimeToScreen 2019 programme on the 19th of September, 2019 at the Zenith House, Iga-Idunganran Primary Healthcare Centre, Iga-Idunganran, Lagos Island.

Related Links:

Publication date: September–October 2019Source: Journal of the American Society of Cytopathology, Volume 8, Issue 5Author(s): Caddie Laberiano, Wilmer Silva Caso

Conditions:   Uterine Cervical Neoplasms;   Cervical Cancer;   Cervical Neoplasms;   Cervix Cancer Interventions:   Drug: Sintilimab;   Drug: quadrivalent HPV vaccine Sponsors:   Buhai Wang;   Innovent Biologics (Suzhou) Co. Ltd. Recruiting

Source: ClinicalTrials.govCategory: Research Source Type: clinical trials

Condition:   Cervical Cancer, Endometrial Cancer,Endometrial Lesion&Adnexal Lesion ,Ectopic Pregnancy&Infertility ,Pelvic Obstructive Disorder&Genital Tract Deformity Intervention:   Sponsors:   Peking Union Medical College Hospital;   Chinese Medical Doctor Association;   Chinese Obstetricians and Gynecologists Association Recruiting

Source: ClinicalTrials.govCategory: Research Source Type: clinical trials

Conditions:   Uterine Cervical Neoplasms;   Cervical Cancer;   Cervical Neoplasms;   Cervix Cancer Interventions:   Drug: Sintilimab;   Drug: quadrivalent HPV vaccine Sponsors:   Buhai Wang;   Innovent Biologics (Suzhou) Co. Ltd. Recruiting

Source: ClinicalTrials.govCategory: Research Source Type: clinical trials

Condition:   Cervical Cancer, Endometrial Cancer,Endometrial Lesion&Adnexal Lesion ,Ectopic Pregnancy&Infertility ,Pelvic Obstructive Disorder&Genital Tract Deformity Intervention:   Sponsors:   Peking Union Medical College Hospital;   Chinese Medical Doctor Association;   Chinese Obstetricians and Gynecologists Association Recruiting

Source: ClinicalTrials.govCategory: Research Source Type: clinical trials

Conditions:   Uterine Cervical Neoplasms;   Cervical Cancer;   Cervical Neoplasms;   Cervix Cancer Interventions:   Drug: Sintilimab;   Drug: quadrivalent HPV vaccine Sponsors:   Buhai Wang;   Innovent Biologics (Suzhou) Co. Ltd. Recruiting

Source: ClinicalTrials.govCategory: Research Source Type: clinical trials

Condition:   Cervical Cancer, Endometrial Cancer,Endometrial Lesion&Adnexal Lesion ,Ectopic Pregnancy&Infertility ,Pelvic Obstructive Disorder&Genital Tract Deformity Intervention:   Sponsors:   Peking Union Medical College Hospital;   Chinese Medical Doctor Association;   Chinese Obstetricians and Gynecologists Association Recruiting

Source: ClinicalTrials.govCategory: Research Source Type: clinical trials

[allAfrica] Johannesburg -The government of Senegal will begin to offer free breast or cervical cancer chemotherapy in public hospitals from October 2019, reports the BBC.

CDC estimates that 92% of cancers caused by HPV could be eliminated in the US if HPV vaccination recommendations in this country are followed Medical laboratories in the United States once processed as many as 55-million Pap tests each year. However, the need for cervical cancer screening tests is diminishing. That’s primarily because the human […]

Source: Dark DailyCategory: Laboratory Medicine Authors: Tags: Instruments & Equipment Laboratory Instruments & Laboratory Equipment Laboratory Management and Operations Laboratory News Laboratory Operations Laboratory Pathology anatomic pathology Brett Giroir MD CDC centers for disease control and Source Type: news

Patients with non-Hodgkin’s lymphoma who received radiation 30 days or less…Read more on AuntMinnie.comRelated Reading:
ASTRO: AI predicts side effects from radiation therapy
ASTRO: Is hormone therapy after prostate surgery needed?
ASTRO: SABR generates immune response to prostate cancer
ASTRO: Cervical cancer deaths rise as women’s centers close
ASTRO: Whole, partial breast RT yield similar cosmetic results



Source link